Robeco Institutional Asset Management B.V. Corcept Therapeutics Inc Transaction History

Robeco Institutional Asset Management B.V.

$50.6 Billion
Q1 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 3,107 shares of CORT stock, worth $223,331. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,107

Holding current value

$223,331

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	BUY	$49.85 - $114.22 $154,883 - $354,881	3,107 New	3,107 $354,000
Q3 2024 Oct 29, 2024	SELL	$29.51 - $46.26 $377,875 - $592,359	-12,805 Reduced 66.55%	6,436 $297,000
Q2 2024 Jul 22, 2024	SELL	$22.21 - $34.48 $54,792 - $85,062	-2,467 Reduced 11.36%	19,241 $625,000
Q1 2024 Apr 24, 2024	SELL	$21.1 - $27.46 $217,308 - $282,810	-10,299 Reduced 32.18%	21,708 $546,000
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $93,745 - $124,187	3,777 Added 13.38%	32,007 $1.04 Million
Q4 2023 Feb 08, 2024	BUY	$24.82 - $32.88 $192,801 - $255,411	7,768 Added 37.96%	28,230 $32 Million
Q2 2023 Jul 24, 2023	SELL	$21.44 - $25.15 $231,487 - $271,544	-10,797 Reduced 34.54%	20,462 $455,000
Q4 2022 Feb 06, 2023	BUY	$19.95 - $29.96 $135,839 - $203,997	6,809 Added 27.85%	31,259 $634,000
Q3 2022 Dec 01, 2022	SELL	$24.7 - $29.12 $111,446 - $131,389	-4,512 Reduced 15.58%	24,450 $626,000
Q3 2022 Oct 26, 2022	SELL	$24.7 - $29.12 $111,446 - $131,389	-4,512 Reduced 15.58%	24,450 $626,000
Q2 2022 Dec 01, 2022	BUY	$17.33 - $25.3 $5,043 - $7,362	291 Added 1.01%	28,962 $689,000
Q2 2022 Jul 27, 2022	BUY	$17.33 - $25.3 $5,043 - $7,362	291 Added 1.01%	28,962 $689,000
Q2 2021 Dec 01, 2022	SELL	$19.97 - $24.43 $209,904 - $256,783	-10,511 Reduced 26.83%	28,671 $631,000
Q2 2021 Jul 28, 2021	SELL	$19.97 - $24.43 $209,904 - $256,783	-10,511 Reduced 26.83%	28,671 $631,000
Q1 2021 Dec 01, 2022	BUY	$23.49 - $30.56 $346,054 - $450,209	14,732 Added 60.25%	39,182 $932,000
Q1 2021 Apr 23, 2021	SELL	$23.49 - $30.56 $248,900 - $323,813	-10,596 Reduced 21.29%	39,182 $932,000
Q4 2020 Dec 01, 2022	BUY	$16.78 - $27.3 $425,003 - $691,454	25,328 Added 103.59%	49,778 $1.3 Million
Q4 2020 Jan 28, 2021	SELL	$16.78 - $27.3 $109,288 - $177,804	-6,513 Reduced 11.57%	49,778 $1.3 Million
Q3 2020 Oct 29, 2020	BUY	$12.46 - $19.98 $156,223 - $250,509	12,538 Added 28.66%	56,291 $981,000
Q1 2020 Apr 30, 2020	BUY	$10.11 - $14.04 $220,216 - $305,819	21,782 Added 99.14%	43,753 $520,000
Q3 2019 Oct 17, 2019	BUY	$10.41 - $14.66 $228,718 - $322,094	21,971 New	21,971 $310,000
Q2 2018 Aug 03, 2018	SELL	$15.3 - $19.69 $269,647 - $347,016	-17,624 Closed	0 $0
Q2 2017 Aug 08, 2017	BUY	N/A	17,624	17,624 $208,000

Others Institutions Holding CORT

# of Institutions

429

Shares Held

84.6M

Call Options Held

1.04M

Put Options Held

1.33M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.7B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Corcept Therapeutics Inc Transaction History